Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.
about
Prostacyclin for pulmonary hypertension in adultsLong term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogueNew treatments for pulmonary arterial hypertension.Recommendations on the management of pulmonary hypertension in clinical practice.Epoprostenol sodium for treatment of pulmonary arterial hypertension.Pulmonary arterial hypertension associated to connective tissue diseases.Pharmacokinetic evaluation of continuous intravenous epoprostenol.The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.Pulmonary hypertension in antiphospholipid syndrome.Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension.Severe pulmonary arterial hypertension in type 1 glycogen storage disease.Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center.Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol.Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension.Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension.Bosentan for the treatment of sclerodermaIntravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center
P2860
Q24246933-42D8BAA7-61B6-4443-B188-0BD1961CCB5DQ28364280-4E47CA66-879A-4067-B4CA-7558369CF285Q34625826-EABBA2C4-D80A-4714-A24A-0C57161C4AE4Q35578998-0BE30CBC-500A-49C2-B108-CF997FEB1D69Q35624220-A6B7C359-B010-4D6F-9EB3-44835376E270Q36283465-8EAF42A7-ECDC-45E0-95E0-CA9D940A2299Q37809538-3FC811C0-D1AE-41A9-8498-894849B6A858Q37837276-B4182265-D9A3-4285-9BED-A6224E7BD6E9Q38325716-0AF7B16B-2B43-42C2-8BA4-1F15B4792DAFQ42667417-65C0B7D8-333B-4414-9868-126A75E8F4ABQ43871209-BB2C4CB4-0973-49CC-8BD2-D28C50C75402Q44175114-8B5676A0-739A-41CB-96D0-CA4993EB8E49Q44205487-44827F04-AA09-47C2-86C6-5E74FE203854Q44225827-4A596510-0A59-49E3-8ED0-F5D6B02611D2Q50048674-1B4A1876-0025-49AF-932C-CB6851A55EE5Q55286186-AC1B370C-90F8-44A3-8A6F-1DFE82BA0464Q56978245-003892CB-3B3E-48EE-A863-0329804A9A94Q58204719-7B56BAC6-4778-4378-8C4B-11D7D8FD65B4
P2860
Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Short-term and long-term epopr ...... ses: results of a pilot study.
@ast
Short-term and long-term epopr ...... ses: results of a pilot study.
@en
type
label
Short-term and long-term epopr ...... ses: results of a pilot study.
@ast
Short-term and long-term epopr ...... ses: results of a pilot study.
@en
prefLabel
Short-term and long-term epopr ...... ses: results of a pilot study.
@ast
Short-term and long-term epopr ...... ses: results of a pilot study.
@en
P2093
P50
P1476
Short-term and long-term epopr ...... ases: results of a pilot study
@en
P2093
P304
P356
10.1183/09031936.99.13613579
P577
1999-06-01T00:00:00Z